CLN — Clariant AG Balance Sheet
0.000.00%
- CH₣2.91bn
- CH₣4.57bn
- CH₣4.15bn
- 77
- 73
- 13
- 54
Annual balance sheet for Clariant AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,004 | 427 | 718 | 593 | 395 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 915 | 1,049 | 1,065 | 964 | 1,030 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,494 | 2,211 | 2,619 | 2,217 | 2,128 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,832 | 2,071 | 1,789 | 1,610 | 1,717 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,933 | 7,038 | 6,188 | 5,347 | 6,264 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,796 | 2,223 | 1,856 | 1,589 | 1,451 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,691 | 4,680 | 3,847 | 3,329 | 3,929 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,242 | 2,358 | 2,341 | 2,018 | 2,335 |
Total Liabilities & Shareholders' Equity | 6,933 | 7,038 | 6,188 | 5,347 | 6,264 |
Total Common Shares Outstanding |